• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

303.3800 USD 9.7100 3.31%

As of 17:20:00 ET on 12/17/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 294.7400 High - Low: 303.8900 - 293.4800 Primary Exchange: NASDAQ GM
Volume: 1,934,367 52-Week Range: 207.4800 - 316.8040 Beta vs XNBI: 0.9996

ETF Chart for IBB

No chart data available.
  • IBB:US 303.5000
  • 1D
  • 1M
  • 1Y
293.6700
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-12-16) 293.9100
Assets (M) (on 2014-12-16) 6,436.7050
Shares out (M) 21.90
Market Cap (M) 6,644.02
% Premium -0.08
Average 52-Week % Premium 0.0063
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +1.91% 1-Year +36.26%
3-Month +8.46% 3-Year +43.44%
Year To Date +29.56% 5-Year +30.34%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 12/16/2014
Name Position Value % of Total
Celgene Corp 5,124,309 564,135,178 8.764%
Amgen Inc 3,493,421 556,991,044 8.653%
Regeneron Pharmaceuticals Inc 1,207,738 478,421,254 7.433%
Biogen Idec Inc 1,419,437 461,501,552 7.170%
Gilead Sciences Inc 4,526,132 454,695,221 7.064%
Vertex Pharmaceuticals Inc 2,602,009 288,445,708 4.481%
Mylan Inc/PA 4,983,615 266,922,419 4.147%
Alexion Pharmaceuticals Inc 1,438,203 255,611,819 3.971%
Illumina Inc 1,357,460 237,799,843 3.694%
BioMarin Pharmaceutical Inc 1,960,260 168,699,976 2.621%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil